SHANGHAI, China, Oct. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of Jeff X. Leng, managing director of General Atlantic LLC, to the WuXi Board of Directors. Mr. Leng is replacing Sean Tong, formerly with General Atlantic, on the WuXi board. General Atlantic is a global growth investor with a long-term investment horizon and an active value-added strategy.
Dr. Ge Li, WuXi's Chairman and Chief Executive Officer commented, "We thank Sean for his invaluable contributions and leadership to the board, and we are pleased to welcome Jeff to the WuXi board. Jeff brings with him invaluable experience as an investor and advisor to growth companies. We will employ his expertise as we position WuXi for the future to meet and anticipate the services that our customers will require as their businesses evolve."
Mr. Leng has 10 years' experience in investment and finance. He has been working for General Atlantic since 2007 and is based in China. Prior to joining General Atlantic, he served as a managing director at Warburg Pincus. Mr. Leng holds an MBA degree from the Wharton School at the University of Pennsylvania.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
device R&D outsourcing company, with operations in China and the United
States. As a research-driven and customer-focused company, WuXi PharmaTech
provides pharmaceutical, biotechnology and medical device companies a broad
and integrated portfolio of laboratory and manufacturing services
throughout the drug and medical device R&D process. WuXi PharmaTech's
services are designed to assist its global partners in shortening the cycle
and lowering the cost of drug and medical device R&D. The operating
subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more
information, please visit: http://www.wuxiapptec.com .
For more information, please contact:
Debra Yu, MD
Vice President Strategy
WuXi PharmaTech (Cayman) Inc.
Vice President of Investor Relations
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2008 PR Newswire.
All rights reserved